EMA Looks Into 'Data Integrity' Issue with Amgen's Tavneos

EMA looks into 'data integrity' issue with Amgen's Tavneos

Concerns about efficacy data in the main trial behind the approvals of Amgen and CSL Vifor's Tavneos have triggered an EU review.

EMA Reviews Vasculitis Drug Over Data Concerns

CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis. Medscape News Europe Source link : https://www.medscape.com/viewarticle/ema-reviews-vasculitis-drug-over-data-concerns-2026a100032g?src=rss Author : Publish date : 2026-01-30 16:29:00 Copyright for syndicated content belongs to the linked Source. The post EMA Reviews Vasculitis Drug Over Da…